NI
PDLI

Numeric Investors’s PDL BioPharma, Inc. PDLI Stock Holding History

Numeric Investors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.74M Buy
1,000,340
+110,700
+12% +$340K 0.02% 554
2017
Q3 		$3.02M Sell
889,640
-361,200
-29% -$1M 0.02% 509
2017
Q2 		$3.09M Sell
1,250,840
-531,600
-30% -$1.22M 0.03% 423
2017
Q1 		$4.05M Buy
1,782,440
+634,600
+55% +$1.4M 0.04% 366
2016
Q4 		$2.43M Buy
1,147,840
+59,200
+5% +$165K 0.02% 463
2016
Q3 		$3.65M Buy
1,088,640
+46,000
+4% +$146K 0.03% 364
2016
Q2 		$3.27M Buy
1,042,640
+11,300
+1% +$37.7K 0.03% 365
2016
Q1 		$3.43M Buy
1,031,340
+17,000
+2% +$53K 0.04% 344
2015
Q4 		$3.59M Buy
1,014,340
+475,940
+88% +$1.99M 0.04% 347
2015
Q3 		$2.71M Buy
538,400
+60,900
+13% +$349K 0.03% 337
2015
Q2 		$3.07M Sell
477,500
-40,959
-8% -$274K 0.04% 326
2015
Q1 		$3.65M Sell
518,459
-775,966
-60% -$5.62M 0.04% 283
2014
Q4 		$9.98M Sell
1,294,425
-912,300
-41% -$7.22M 0.13% 157
2014
Q3 		$16.5M Buy
2,206,725
+484,700
+28% +$4.5M 0.24% 94
2014
Q2 		$16.7M Buy
1,722,025
+13,195
+0.8% +$118K 0.25% 106
2014
Q1 		$14.2M Sell
1,708,830
-708,234
-29% -$6.07M 0.24% 102
2013
Q4 		$20.4M Buy
2,417,064
+1,722,326
+248% +$14.5M 0.34% 67
2013
Q3 		$5.54M Sell
694,738
-211,200
-23% -$1.7M 0.1% 198
2013
Q2 		$6.99M Buy
+905,938
New +$7.06M 0.14% 153

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Numeric Investors's PDLI Position: Q4 2017 in Review

Numeric Investors increased its PDL BioPharma, Inc. (PDLI) stake by 12% in Q4 2017, buying an estimated $340K and bringing the position to 1,000,340 shares worth $2.74M. The position accounts for 0.02% of the portfolio, ranked #554.

Numeric Investors first reported a position in PDLI in Q2 2013 and has held it in 19 quarters since. The position peaked at $20.4M in Q4 2013. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

  • Numeric Investors held 1,000,340 shares of PDL BioPharma, Inc. worth $2.74M as of Q4 2017.
  • Numeric Investors bought 110,700 PDL BioPharma, Inc. shares in Q4 2017, an estimated $340K.
  • PDL BioPharma, Inc. made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #554 holding.
  • Numeric Investors first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 19 quarters since.
  • Numeric Investors's PDL BioPharma, Inc. position peaked at $20.4M in Q4 2013.
  • 187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.